Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

CRISPR tech startup Mammoth Biosciences is among the business that revealed backing from the National Institutes of Health (NIH) Fast Acceleration of Diagnostics (RADx) program on Friday. Massive got an agreement to scale up its CRISPR-based SARS-CoV-2 diagnostic test in order to assist deal with the screening scarcities throughout the U.S. Mammoth’s CRISPR-based technique might possibly […]…